Skip to content
value.today

Color Genomics, Inc.

🇺🇸 Burlingame, California, USABiotechnologyFounded 2013

Formerly Color Global, Inc.

Total raised
$301 M
4 rounds on record
Latest round
$46 M
Oct 2021
First round on record
Aug 2016
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Color Genomics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2021$46 MNo. 4$10 to $50 million

Color Genomics, Inc.: Raise no. 4, Oct 2021

Investors in this round

18 investors had bought by the notice of Nov 9, 2021: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$46 M of $100 M offered; $54 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael L. Herring · Executive Officer
  • Othman Laraki · Executive Officer, Director
  • Elad Gil · Director
  • Hemant L. Taneja · Director
  • Susan L. Wagner · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Othman Laraki, CEO and President. Source: SEC Form D, newest notice filed Nov 9, 2021. Read the notice at the SEC.

equitySEC
Dec 2020$127 MNo. 3$50 to $250 million

Color Genomics, Inc.: Raise no. 3, Dec 2020

Investors in this round

13 investors had bought by the notice of Jan 4, 2021: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$127 M of $167 M offered; $40 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Othman Laraki · Executive Officer, Director
  • Sherwin L Chen · Executive Officer
  • Gil Elad · Director
  • Hemant Taneja · Director
  • Susan L Wagner · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Othman Laraki, Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 4, 2021. Read the notice at the SEC.

equitySEC
Aug 2017$89 MNo. 2$50 to $250 million

Color Genomics, Inc.: Raise no. 2, Aug 2017

Investors in this round

51 investors had bought by the notice of Nov 14, 2017: 51 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$89 M of $102 M offered; $12 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Othman Laraki · Executive Officer, Director
  • Elad Gil · Director
  • Susan L. Wagner · Director
  • Taneja Hemant · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Othman Laraki, President and CEO. Source: SEC Form D and 1 amendment, newest notice filed Nov 14, 2017. Read the notice at the SEC.

equitySEC
Aug 2016$39 MNo. 1$10 to $50 million

Color Genomics, Inc.: Raise no. 1, Aug 2016

Investors in this round

38 investors had bought by the notice of Aug 29, 2016: 38 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$39 M of $48 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Elad Gil · Executive Officer, Director
  • Othman Laraki · Executive Officer, Director
  • Taneja Hemant · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Othman Laraki, President. Source: SEC Form D, newest notice filed Aug 29, 2016. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Color Genomics, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2021).

    SEC Form D · Nov 2021

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Nov 2021

That is all the official record says: Color Genomics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Color Genomics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 51 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Color Genomics, Inc.
NameRoleNamed in
Michael L. HerringExecutive officerNov 2021
Othman LarakiExecutive officerNov 2021
Sherwin L ChenExecutive officerJan 2021
Elad GilExecutive officerAug 2016
Elad GilDirectorNov 2021
Hemant L. TanejaDirectorNov 2021
Othman LarakiDirectorNov 2021
Susan L. WagnerDirectorNov 2021
Gil EladDirectorJan 2021
Hemant TanejaDirectorJan 2021
Susan L WagnerDirectorJan 2021
Taneja HemantDirectorNov 2017